权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Specificity of ABCA7-mediated lipid efflux and its effects on intracellular lipid metabolism in neural cells

ABCA7介导的脂质流出的特异性及其对神经细胞细胞内脂质代谢的影响

基本信息

批准号：
10591201
负责人：
Nicholas Lyssenko
金额：
$ 22.32万
依托单位：
TEMPLE UNIV OF THE COMMONWEALTH
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-01-01 至 2024-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10591201
关键词：
ATP-binding cassette transport Affect African ancestry Age Age Years Alzheimer&apos s Disease Alzheimer&apos s disease model Alzheimer&apos s disease pathology Alzheimer&apos s disease patient Alzheimer&apos s disease risk Amyloid beta-Protein Amyloid beta-Protein Precursor Animals Architecture Astrocytes Biochemical Brain Cell membrane Cells Cessation of life Cholesterol Cholesterol Homeostasis Chromosome 21 Data Dementia Dimensions Disease Down Syndrome Early Onset Familial Alzheimer&apos s Disease Electrospray Ionization Engineering Etiology European ancestry Exhibits Genes Genetic Genetic Predisposition to Disease Genetic study Glioblastoma Healthcare Systems High Density Lipoproteins Hippocampus Human Individual Induced pluripotent stem cell derived neurons Investigation Knowledge Label Late Onset Alzheimer Disease Lecithin Link Lipids Longevity Mass Spectrum Analysis Measures Mediating Mediator Metabolic Microglia Nerve Degeneration Neuroblastoma Neurons Parietal Lobe Pathogenesis Pathologic Pathology Performance Phospholipids Phosphotransferases Physiology Population Productivity Proteins Publishing Radioactive Research Personnel Risk Role Shotguns Specificity Testing Thin Layer Chromatography Tissues Trisomy Variant comparative extracellular gene function genome wide association study high density lipoprotein-1 lipid metabolism lipidomics loss of function loss of function mutation member mouse model neural neuron loss particle preference tau Proteins

项目摘要

Project Summary/Abstract Alzheimer's disease (AD) dementia has emerged as a major burden on the healthcare system and a major barrier to human longevity, especially productive human longevity. Genetics of familial early-onset AD, pathological changes in the brain of sporadic late-onset AD patients and pathological changes in the brain of individuals with Down syndrome, who frequently have increased expression of amyloid precursor protein (APP) owing to partial trisomy of chromosome 21, all point to APP and its cleavage product amyloid β (Aβ) peptide as major causative factors in AD pathogenesis. However, other factors may also play a role. The genome-wide association studies (GWAS) of the architecture of common genetic predisposition to AD, genetic investigations of rare loss-function mutations and studies in mouse models of AD have implicated ATP-binding cassette transport subfamily A member 7 (ABCA7) in AD pathogenesis. A closely related protein, ATP-binding cassette transport subfamily A member 1 (ABCA1) has been implicated in AD in the GWAS and animal studies. In our preliminary data, we show that individuals with low ABCA7 protein levels have a greater risk for developing AD pathology. Both ABCA1 and ABCA7 mediate formation of high-density lipoprotein (HDL) particles from cell lipids. In preliminary data, we show that ABCA7- and ABCA1-HDL significantly differ in the lipid composition. Recently, we published the altered lipidostasis hypothesis that draws on the paradigms provided by ABCA1 and another ABC A transporter, ABCA4, and poses the existence of a neurodegenerative lipid that continuously arises during normal physiology and promotes AD pathogenesis when it is not eliminated from neural cells by ABCA7. ABCA1 and ABCA4 eliminate from specific cells deleterious lipids that these cells accumulate during normal function. The purpose of the present exploratory project is to conduct comparative ABCA7 vs ABCA1 studies in specificity of lipid efflux in neural cells and to test the prediction of the lipidostasis hypothesis of AD that in the neural tissue ABCA7 mediates efflux of a specific lipid species (i.e., the neurodegenerative lipid) that is not effluxed significantly by ABCA1. To test this prediction, we will use metabolic radioactive labeling of lipids/high performance thin layer chromatography (HPTLC) and multidimensional electrospray ionization `shotgun' mass spectrometry lipidomics to compare ABCA7- and ABCA1-mediated lipid efflux/HDL and the effects that this efflux/HDL formation has on the lipid composition of the plasma membrane and whole cell in microglia C20, astrocyte glioblastoma A172 and neuroblastoma SK-N- SH cells inducibly expressing ABCA7 or ABCA1.

项目总结/文摘